A new care model asks: what matters most to people with diabetic foot ulcers?
NCT ID NCT07781111
First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time
Summary
This study tests whether adding a proactive palliative care approach to routine diabetic foot ulcer care is feasible and acceptable. The model includes structured conversations to understand patients' concerns, priorities, and preferences for care, with relatives involved when appropriate. Researchers will gather feedback from patients, relatives, and healthcare professionals to see if this approach fits into daily practice and supports better care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A proactive palliative care model that includes structured conversations about patients' health concerns, priorities, and care preferences.
- What this could lead to
- If successful, this approach could improve quality of life and align care with what matters most to people with diabetic foot ulcers.
- What could go wrong
- This is a small feasibility study, so it may not show clear benefits. It also depends on how well clinicians and patients accept the conversations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 484 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population comprises adult patients with diabetic foot ulcers (DFU) receiving care at two participating outpatient wound clinics, their relatives or close persons where applicable, and healthcare professionals involved in DFU care and in the implementation and delivery of the ProActive model. For Studies 1-3, patient participants are those who are offered and participate in a Status Conversation as part of the ProActive model. Study 4 includes the broader population of all adult patients with DFU who are newly referred to the participating clinics during the 12-month test phase or who develop a new or recurrent DFU during ongoing follow-up, regardless of whether they are offered or participate in a Status Conversation.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Study 1-3: Inclusion Criteria: Health professionals: \- Healthcare professionals involved in DFU care and in the implementation and delivery of the ProActive model at one of the participating sites, including specialized wound care nurses and vascular or orthopaedic surgeons. Patient and relatives * Aged ≥18 years. * Have a diabetic foot ulcer (DFU). * Receive care at one of the two participating outpatient wound clinics. * Are offered and participate in a Status Conversation as part of the ProActive model in routine clinical practice. * Are able to provide informed consent. Exclusion Criteria: Healthcare professionals: -Not involved in DFU care or in the implementation or delivery of the ProActive model at the participating sites. Patients and relatives: * Unable to provide informed consent. * Do not otherwise meet the relevant inclusion criteria. Study 4: Inclusion Criteria: * Aged ≥18 years. * Have a diabetic foot ulcer (DFU). * Are newly referred to one of the participating outpatient wound clinics during the 12-month test phase, or develop a new or recurrent DFU during ongoing follow-up at one of the participating clinics. * Included regardless of whether they are identified as potentially relevant for, offered, or participate in a Status Conversation. Exclusion Criteria: * Patients who are not newly referred during the test phase and who do not develop a new or recurrent DFU during ongoing follow-up at one of the participating clinics. * Patients with insufficient Danish language skills to understand questionnaires or study instructions, or with cognitive impairment that prevents understanding of instructions or participation in a Status Conversation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Advance care planning are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can listening to music calm anxiety at the end of life?
- A personal guide through the healthcare maze: could a navigator save limbs from diabetes?
- Can a simple mouth rinse ease soreness for patients fed by tube?
- A 45-minute chat could change how advanced cancer patients face tough decisions
- Can Lab-Grown skin cells close stubborn diabetic wounds?
- Can a collagen patch outperform fish skin in healing diabetic wounds?